Endo International

Phone: +353 1 268 2000

Web: https://www.endo.com/contact

Type	public liability company
Traded as	ENDPQ
ISIN
Industry	Pharmaceutical
Predecessor	Endo Pharmaceuticals Inc. (before the 2014 tax inversion to Ireland)
Founded	1997 (1997)
Headquarters	(Legal) Dublin, Ireland (Operational) Malvern, Pennsylvania, United States.
Key people	Paul Campanelli (CEO) Blaise Coleman (CFO)
Revenue	US$3,468.8 million (2017)
Number of employees	2,910
Website	endo.com

Endo is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them.

For detailed contact information visit location pages below.